Waugh, Elspeth M, Jarrett, Ruth F, Shield, Lesley et al. · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2011 · DOI
Researchers tested whether a virus called XMRV, which had been found in some ME/CFS patients, might cause blood cancers like lymphoma and leukemia. They checked blood samples from 368 patients with these cancers and 507 control samples using three different sensitive tests. The virus was not found in any cancer patient samples, suggesting XMRV is not a major cause of these blood cancers.
This study is relevant to ME/CFS research because early reports linked XMRV to ME/CFS, raising concerns about whether the virus might trigger additional serious complications including cancer. By systematically testing whether XMRV causes lymphoid malignancies, this research helps clarify the virus's actual health impact and resolves one potential complication pathway. The negative findings contributed to the growing evidence that XMRV's role in ME/CFS was unclear and required further investigation.
This study does not prove that XMRV is completely absent from all human populations or that it plays no role in ME/CFS itself—only that it is not associated with common lymphoid cancers in the UK. The absence of XMRV in cancer samples does not establish whether XMRV causes other diseases or whether it was truly present in the original ME/CFS patient cohorts. Geographic and population-specific limitations mean findings may not generalize to all populations worldwide.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →